PSA screening for prostate cancer reduces disease-specific deaths, new review shows

A new review published by the Cochrane organization found that PSA screening reduces the risk of death from prostate cancer, with about two fewer deaths for every 1,000 men screened. The review analyzed results from six trials involving 800,000 participants conducted in Europe and North America. The benefits of PSA screening are considered marginal.